GOLIMUMAB ADMINISTERED SUBCUTANEOUSLY EVERY 4 WEEKS IN ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE: WEEK 24 RESULTS OF GO-FORWARD STUDY Rubbert, A., Keystone, E., Genovese, M., Klareskog, L., Hsia, E. C., Zrubek, J., Wu, Z., Rahman, M. U., GO-FORWARD Study Investigators OXFORD UNIV PRESS. 2009: I92

View details for Web of Science ID 000266198600301